(Q43786514)

26 November 2017

title

Levosimendan is a mitochondrial K(ATP) channel opener (English)

1 reference

26 November 2017

2

1 reference

26 November 2017

Kopustinskiene DM

1

1 reference

26 November 2017

Saris NE

series ordinal

3

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

European Journal of Pharmacology

26 November 2017

published in

1 reference

26 November 2017

volume

428

1 reference

26 November 2017

issue

3

1 reference

26 November 2017

page(s)

311-314

1 reference

The role of mitochondrial potassium fluxes in controlling the protonmotive force in energized mitochondria.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901350-4

Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mitochondria: spectral and metabolic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901350-4

Cation transport in mitochondria--the potassium cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901350-4

Opening mitochondrial K(ATP) in the heart--what happens, and what does not happen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901350-4

The role of mitochondrial KATP channels in cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901350-4

ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901350-4

ATP-sensitive K+ channel in the mitochondrial inner membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901350-4

Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901350-4

Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901350-4

Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901350-4

Effect of a calcium-sensitizing agent, levosimendan, on the postcardioplegic inotropic response of the myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901350-4

Comparison of the vasorelaxing effect of cromakalim and the new inodilator, levosimendan, in human isolated portal vein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901350-4

Mitochondria: a new target for K channel openers?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901350-4

Mitochondrial K(ATP) channels: probing molecular identity and pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901350-4

Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901350-4

10.1016/S0014-2999(01)01350-4

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference